v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 19,572 $ 24,983
Marketable securities, current 104,947 118,061
Prepaid expenses 2,615 3,917
Other current assets 5,251 1,254
Total current assets 132,385 148,215
Marketable securities, non-current 0 8,986
Operating lease right-of-use assets 8,206 8,608
Property and equipment, net 18,634 19,309
Other assets 3,940 7,244
Total assets 163,165 192,362
Current liabilities:    
Accounts payable 0 1,612
Accrued liabilities 7,905 9,515
Deferred revenue, current 34,586 32,937
Other current liabilities 2,533 2,606
Total current liabilities 45,024 46,670
Deferred revenue, long-term 24,252 33,350
Long-term debt, net of current portion 35,737 35,491
Operating lease liabilities 9,009 9,564
Other liabilities 1,661 1,625
Total liabilities 115,683 126,700
Commitments and contingencies (Note 10) 0 0
Stockholders’ equity    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares at March 31, 2022 and December 31, 2021; issued and outstanding: 250 shares at March 31, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value: Authorized: 150,000,000 shares at March 31, 2022 and December 31, 2021; issued and outstanding: 56,305,049 shares at March 31, 2022 and 56,305,049 shares at December 31, 2021 56 56
Additional paid-in capital 421,386 417,704
Accumulated other comprehensive loss (299) (48)
Accumulated deficit (373,661) (352,050)
Total stockholders’ equity 47,482 65,662
Total liabilities and stockholders’ equity $ 163,165 $ 192,362

Source